Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) (2017-2021) – National Institute of Child Health and Human Development

The 21st Century Cures Act established PRGLAC to advise the HHS secretary regarding gaps in knowledge and research on safe and effective therapies for pregnant women and lactating women. PRGLAC was tasked with identifying these gaps and reporting its findings back to the HHS Secretary.
Federal members included the directors of NIH, NICHD, the Centers for Disease Control and Prevention, the HHS Office on Women’s Health, and the Commissioner of Food and Drugs, U.S. Food and Drug Administration. Non-federal members included representatives from relevant medical societies, non-profit organizations, and industry.
PRGLAC submitted its recommendations to the HHS secretary in 2019 and completed its work in 2021.
Aaron Pawlyk, Obstetric and Pediatric Pharmacology and Therapeutics Branch 
Email: pawlykac@mail.nih.gov 
Version 6.3.0

source

Leave a Comment